investigating the efficacy of cognitive behavioral therapy in patients with substance use disorder and comorbid ADHD. A randomized controlled trial with cognitive behavioral therapy.

investigating the efficacy of cognitive behavioral therapy in patients with substance use disorder and comorbid ADHD. A randomized controlled trial with cognitive behavioral therapy. - nvt

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON37930

Enrollment

150

Registered

2011-10-10

Start date

2011-07-12

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

verslaving ADHD attention-deficit hyperactivity disorder

Interventions

All patients receive addiction treatment. Moreover, patients are randomzed to 2 conditions: Treatment as Usual, or Treatment as Usual plus Cognitive Behavioral Therapy (CBT). This CBT consists of 7

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age 18-60 years - current DSM-IV diagnosis of adult ADHD - current DSM-IV diagnosis of Substance Use Disorder - able to provide written informed consent and to comply with all study procedures.

Exclusion criteria

Exclusion criteria: - severe neurological or psychiatric disorders (e.g. Parkinson's disease, dementia, epilepsy, psychosis, bipolar depression) that require psychotropic medications. - inability to read/ write Dutch language

Design outcomes

Primary

Measure	Time frame
During the trial, the Dutch version of the ADHD rating scale will be completed three times (at the start of the trial, at the end, and at follow-up (3 months after the last CBT session).	—

Secondary

Measure	Time frame
- TLFB (Time Line Follow Back): self-report measure for substance use - Beck Depression Inventory (BDI) - Beck Anxiety Inventory (BAI) - EQ-5: quality of life - TIC-P (health care consumption and production losses) - neurocognitive task: Stroop - Urine checks (cocaine, amphetamines, XTC, opioids, cannabis, benzodiazepines, alcohol)	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)